monoclonal antibody 14G2A
Term · Oncology and biomedicine · MLC-T-ONC-015245
A murine monoclonal antibody directed against the ganglioside GD2 with potential antineoplastic activity. Monoclonal antibody 14G2A binds to the ganglioside GD2 and induces antibody-dependent cell mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.
| Identifier | MLC-T-ONC-015245 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MOAB 14G2A |
| Synonyms | 14G2A; 14G2A, monoclonal antibody; antibody 14G2A, monoclonal |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015245",
"term": "monoclonal antibody 14G2A",
"field": "Oncology and biomedicine",
"definition": "A murine monoclonal antibody directed against the ganglioside GD2 with potential antineoplastic activity. Monoclonal antibody 14G2A binds to the ganglioside GD2 and induces antibody-dependent cell mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.",
"abbreviation": "MOAB 14G2A",
"synonyms": [
"14G2A",
"14G2A, monoclonal antibody",
"antibody 14G2A, monoclonal"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/monoclonal-antibody-14g2a/"
}
Record 11,223 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.